Abelard Lindsay retweeted
Urolithin A: Potential to enhance autophagic clearance and mitigate neuroinflammation in Alzheimer’s disease
sciencedirect.com/science/ar…
Abelard Lindsay retweeted
Spouses of Alzheimer's patients are 6 times more likely to develop Alzheimer's themselves. They share daily saliva exchange for decades. Their oral bacteria converges to the same strains.
In 2019 Cortexyme published a paper in Science Advances showing Porphyromonas gingivalis, the bacterium behind gum disease, was present in over 90% of postmortem Alzheimer's brains. They also found its DNA in the cerebrospinal fluid of living Alzheimer's patients.
P. gingivalis is the keystone pathogen of periodontitis. The CDC says 47% of American adults over 30 have periodontitis right now.
The mechanism is specific. P. gingivalis produces enzymes called gingipains. Two types: one cuts proteins at lysine residues, the other at arginine. Tau, the protein that holds your neuronal scaffolding together, is loaded with both amino acids. In cell culture, gingipains shred soluble tau within one hour of infection. The fragments seed the paired helical filaments that become tangles. Tangles are Alzheimer's.
Mice fed P. gingivalis through the mouth grew amyloid plaques in their brains. Hippocampal neurons died. The bacteria crossed the blood-brain barrier and started chewing through the same proteins that fail in human Alzheimer's patients.
Cortexyme built a drug called atuzaginstat to block gingipains. Phase 1 was clean. They ran a 643-patient Phase 2/3 trial called GAIN.
The FDA hit it with a partial clinical hold for liver toxicity. The drug missed both primary endpoints. In August 2022 Cortexyme shut the program down, renamed itself Quince, and pivoted to bone disease.
The subgroup with the highest baseline P. gingivalis loads still showed cognitive improvement on secondary endpoints. The bacteria itself kept showing up in postmortem brains across independent studies after the trial closed.
Periodontal disease shows up 10 to 20 years before cognitive symptoms in people who later develop Alzheimer's. By the time someone forgets a name, the bacteria has been working for two decades.
The intervention point is upstream of your skull.
Abelard Lindsay retweeted
He was diagnosed with rare bone cancer.
He exhausted the standard of care: surgery, radiation, chemotherapy.
There were no viable trials for his case. No approved treatments. No doctor willing to promise any potential for hope.
That’s where most journeys end.
Not his.
Abelard Lindsay retweeted
Known as cyclin D-binding myb-like transcription factor 1 or DMTF1, the scientists found that this protein's levels are repressed in the “aged” neural stem cells and that restoring it is sufficient to restore the regeneration capabilities of such neural stem cells.
healthandme.com/health-welln…
Abelard Lindsay retweeted
The 70% Life Extension Nobody Is Talking About
Two cheap drugs. One university lab. A 73% increase in remaining lifespan for elderly mice. The longevity breakthrough that should be front-page news and why decentralized science may be the only force that can bring it to your medicine cabinet.
Oxytocin and Inhibitor Extend Mouse Lifespan
Combining oxytocin and Alk5 inhibitor extended elderly mouse lifespan by 73%. Inexpensive drugs, no gene therapy. Major longevity paper.
Why Important: Demonstrates affordable pharmacological approaches to longevity, bridging natural hormones with targeted inhibition for human applications.
doi.org/10.18632/aging.20630…
Abelard Lindsay retweeted
The math on this project should mass-humble every AI lab on the planet.
1 cubic millimeter. One-millionth of a human brain. Harvard and Google spent 10 years mapping it. The imaging alone took 326 days. They sliced the tissue into 5,000 wafers each 30 nanometers thick, ran them through a $6 million electron microscope, then needed Google’s ML models to stitch the 3D reconstruction because no human team could process the output.
The result: 57,000 cells, 150 million synapses, 230 millimeters of blood vessels, compressed into 1.4 petabytes of raw data. For context, 1.4 petabytes is roughly 1.4 million gigabytes. From a speck smaller than a grain of rice.
Now scale that. The full human brain is one million times larger. Mapping the whole thing at this resolution would produce approximately 1.4 zettabytes of data. That’s roughly equal to all the data generated on Earth in a single year. The storage alone would cost an estimated $50 billion and require a 140-acre data center, which would make it the largest on the planet.
And they found things textbooks don’t contain. One neuron had over 5,000 connection points. Some axons had coiled themselves into tight whorls for completely unknown reasons. Pairs of cell clusters grew in mirror images of each other. Jeff Lichtman, the Harvard lead, said there’s “a chasm between what we already know and what we need to know.”
This is why the next step isn’t a human brain. It’s a mouse hippocampus, 10 cubic millimeters, over the next five years. Because even a mouse brain is 1,000x larger than what they just mapped, and the full mouse connectome is the proof of concept before anyone attempts the human one.
We’re building AI systems that loosely mimic neural networks while still unable to fully read the wiring diagram of a single cubic millimeter of the thing we’re trying to imitate. The original is 1.4 petabytes per millionth of its volume. Every AI model on Earth fits in a fraction of that.
The brain runs on 20 watts and fits in your skull. The data center required to merely describe one-millionth of it would span 140 acres.
Abelard Lindsay retweeted
Study reveals how intermittent fasting regulates aging through autophagy
phys.org/news/2024-08-reveal…
Abelard Lindsay retweeted
FDA clears first human trial of epigenetic reprogramming therapy
longevity.technology/news/fd…
Abelard Lindsay retweeted
New paper! Remember this:
nature.com/articles/s41536-0…
showing massive nerve growth following zolmitriptan application in frog model?
Well, now here it is in mammals!
sciencedirect.com/science/ar…
"Sustained Serotonergic Stimulation Platform for Peripheral Axonal Regeneration" @TuftsBME
@TuftsEngineer @jugalsahoo @KaplanLab_Tufts
Abelard Lindsay retweeted
Coffee drinkers are biologically younger than those who abstain—and that could help explain why people who drink 2–3 cups per day have up to a 27% lower risk of dying from any cause.
While this doesn’t necessarily mean coffee causes a longer life, there’s compelling biological plausibility behind the link, much of it rooted in epigenetics.
Research shows that coffee influences DNA methylation at 11 specific CpG sites tied to inflammation, metabolism, and age-related diseases. These changes are likely driven by coffee’s rich mix of bioactive compounds, particularly chlorogenic acids, which can act on the cellular machinery that regulates gene expression.
Several studies have also found that moderate coffee intake—about 1 to 3 cups daily—is associated with slower biological aging, reflected in reduced epigenetic and PhenoAge acceleration. On average, each daily cup corresponds to a 0.12-year reduction in epigenetic age.
In other words, regular coffee consumption seems to slow the ticking of our biological clocks, offering one possible explanation for the lower rates of cardiovascular disease, diabetes, and neurodegeneration observed in habitual coffee drinkers.
Coffee may be the most overlooked anti-aging tool hiding in plain sight
Emerging research reveals that coffee can actively slow biological aging—each daily cup consumed correlates with a 0.7–1 year reduction in epigenetic age
Drinking 3+ cups daily reduces the risk of accelerated aging by 34–41% and lowers death risk from all causes (compared to non-coffee drinkers) by 27%, translating to nearly two extra years of life
Even decaf delivers similar powerful benefits
The takeaway is clear: Regular coffee drinkers consistently live longer
Abelard Lindsay retweeted
This is Dr. Michael Levin (@drmichaellevin).
He’s a visionary biologist of our century.
Most think biology is all about genes & chemistry—Levin proves it’s also about bioelectricity.
Here are his 5 mind-blowing discoveries (& how they could redefine your health): 🧵
Abelard Lindsay retweeted
Anti-Aging Breakthrough: Scientists discover a natural antioxidant that could stop Gray Hair
As humans age, the color of our hair changes from its natural hue to gray or white. This process is primarily driven by the gradual reduction in melanin production, the pigment responsible for hair color. Melanin is produced by specialized cells in hair follicles called melanocytes. Over time, these cells produce less melanin, leading to hair losing its color and turning gray or white.
The timing of this change is largely determined by genetics, meaning that when and how quickly a person’s hair turns gray is influenced by their family history. For some, graying may begin in their 20s, while others may retain their natural color well into middle age or beyond.
"Researchers from Nagoya University in Japan have identified luteolin, an antioxidant found in certain vegetables, as a potential solution for preventing hair graying. Their study on mice showed that luteolin helped maintain fur color by preserving endothelin expression, which supports melanocyte activity responsible for hair pigmentation."
"The researcher’s study focused on three antioxidants - luteolin, hesperetin, and diosmetin - to assess their anti graying effects in mice that were bred to go gray like humans. The difference was startling, the mice that received luteolin retained their black fur, even as their cage mates’ fur turned gray, regardless of whether the luteolin was given externally or internally"
Abelard Lindsay retweeted
RFK Jr putting Methylene Blue in his water while flying is prime we’re so back.
MB while flying
- Mitigates any radiation burden
- Protects against oxidative stress
- Anti viral so you don’t catch a cold
- Boosts autophagy if fasting on flight
Also that dose I don’t recommend, but he’s spearheading a movement so I get it.
Abelard Lindsay retweeted
By comparing thousands of laboratory-grown dopamine neurons from humans, chimpanzees, macaques and orangutans, researchers found that human dopamine neurons express more genes that boost the activity of damage-reducing antioxidants than do those of the other primates.
pulse.ly/nmikevbvq6
Abelard Lindsay retweeted
Replying to @MeenaJea @bryan_johnson
Apheresis Rejuvenation Therapy is a treatment that involves filtering the blood to remove harmful substances, such as inflammatory proteins and lipids. It’s believed to help reduce the risk of age-related diseases and promote longevity by essentially “cleansing” the blood.
Abelard Lindsay retweeted
3/ The findings are very reassuring regarding my health program and the Blueprint stack and some of the latest changes we introduced.
Many of the reported findings echo my protocol and system, which is fascinating as it indicates that continuous measurement and optimization for actual biomarkers and performance indicators automatically consolidates the interventions that best slow down epigenetic biological age.
Here are some examples:
Abelard Lindsay retweeted
CRISPR–Cas9 screens reveal regulators of ageing in neural stem cells
nature.com/articles/s41586-0…
Abelard Lindsay retweeted
Drinking 3 cups of coffee or 200–300 mg of caffeine per day lowers your risk of developing diabetes, heart disease, or stroke by up to 48%!
Compared to people who don’t consume coffee or caffeine, people who are moderate consumers are less likely to have new-onset cardiometabolic disease, according to a new study. They’re also less likely to progress to multimorbidity—the presence of two or more conditions—during a follow-up period of nearly 12 years.
Although a moderate intake was associated with the lowest risk, even high intakes of coffee and caffeine were protective!
For example, consuming 4–5 cups of coffee per day was associated with a 35–40% lower disease risk compared to people who never consume coffee. For caffeine, consuming as much as 400 mg or more per day was associated with a 41% lower risk.
This might have something to do with lipoproteins—metabolites expressing HDL subclasses were positively associated with moderate coffee intake while those expressing VLDL subclasses showed a negative association.
There is also good news for tea drinkers. People consuming 3–4 or more cups of tea per day were up to 40% less likely to develop cardiometabolic disease than non-tea drinkers.
The takeaway?
I don’t think this means you should drink more coffee, caffeine, or tea in hopes of reducing your disease risk. But if you’re already drinking a moderate amount of caffeinated beverages, I think it’s safe to say that you’re not harming your health, and you might even be protecting yourself against certain diseases.
doi: 10.1210/clinem/dgae552
Abelard Lindsay retweeted
Six drivers of aging identified among genes differentially expressed with age
biorxiv.org/content/10.1101/…



























